
A seed and early-stage venture firm backing digital companies in essential industries such as healthcare and energy

Evergreen early-stage venture firm in Charleston backing scalable start-ups, mainly in the Southeast

An evergreen investor in Charleston, Alerion makes one new investment per quarter, mostly in start-ups from the Southeast. It focuses on early-stage investments in scalable businesses.
The firm targets one new company investment per quarter. It will consider a company once it has reached initial market and revenue traction after proof of concept, including a functional product. It also considers opportunistic investments in growth-stage businesses with a nearer-term exit potential.
In every stage, the firm prefers to co-invest with other experienced venture investors. It will look at companies nationally, outside the West Coast and Northeast, and it has a preference for companies headquartered in the Southeast.
Alerion considers companies in a variety of industries, provided they are capital-efficient and target markets large enough to allow substantial scale and return on investment. Its main interests are software sold to businesses and services delivered with technology, with healthcare software and energy-saving technologies considered more selectively.
It rules out consumer-facing firms, drug discovery work, medical devices, power generation and project finance.
The firm says its team supports entrepreneurs with experience and relationships in running operations, selling, product development, finance and bookkeeping, as well as mergers and acquisitions. It was founded in 2014, and it describes its team members as having experience in acquisitions, international sales, research and development, due diligence and operations.
Its material lists the companies it has invested in. One example is Case Status, which the firm describes as a client communication platform for contingency law firms, including text, app and web services.
Alerion Ventures is an evergreen venture capital firm that invests in early-stage start-ups able to grow substantially. It is based in Charleston, South Carolina, and works mainly with entrepreneurs in the Southeast.
Capital-efficient businesses that already have some market and revenue traction. It leans towards software sold to companies and services delivered with technology, and looks more sparingly at healthcare software and energy-saving technology. It rules out consumer-facing companies, and also drug discovery, medical devices, energy generation and project finance.
Summary written by TrustList from the business's own published information, Nov 2026.
2 images - click to enlarge
Alerion Ventures is ranked on 1 TrustList ranking at #7.
Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. Alerion Ventures has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.
It is the only one of the 46 here listing accounting and one of 3 here listing medical.
Of the 46 here, 11 also cover partners and 9 also cover early stage; 13 also work in San Francisco and 11 also work in Silicon Valley.
Behind MITA Ventures.
As of 2026-11-16. Organic ranks only; sponsored placements are never ranks. How TrustList ranks
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Alerion Ventures.
Similar listings buyers compare against this one.

A seed and early-stage venture firm backing digital companies in essential industries such as healthcare and energy

New York boutique venture firm investing in growth-stage technology companies across several sectors

Early-stage investor supporting capital-efficient founders in North America from pre-seed to Series B

Canadian investor and adviser helping business-to-business enterprise software start-ups grow

Early-stage investor in software companies using a shared earnings agreement instead of equity

European technology investor funding companies from early stage to growth, with deeptech and greentech funds

Investment manager backing early-stage cannabis and other emerging-industry companies for institutional investors

Korean investment manager running growth-stage venture and secondary funds for institutional investors
Everything here links back to the same verified catalogue. Pick your next stop.